SCHEMBL21391577

SCHEMBL21391577

C=C(N)N(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1577819 0.78
SCHEMBL14289016 0.75
SCHEMBL21481183 0.72
SCHEMBL18866528 0.72
SCHEMBL17030632 0.72
SCHEMBL247472 0.67
SCHEMBL2992150 0.67
SCHEMBL417661 0.67
Trimethylammonium SCHEMBL27842322 0.67
SCHEMBL23962218 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11534427-B2 Applications of novel thiazole derivative in treating inflammatory bowel diseases EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-12-27 US disclosed
WO-2021000248-A1 METHOD AND APPARATUS FOR CONTINUOUS SYNTHESIS OF CYCLOPROPANE COMPOUNDS 凯莱英医药集团(天津)股份有限公司 2021-01-07 WO disclosed
EP-2675783-B1 ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES CO (US) 2020-04-22 EP disclosed
US-20190290620-A1 APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2019-09-26 US disclosed